Search Results
Results found for "positive allosteric modulators"
- Pharmacology at Your Fingertips: Terry’s Corner Launches
Ligand Activation in NMBR Simulations show how two ligands differently activate class A GPCR NMBR, with allosteric communication hubs modulating signaling, advancing antipruritic drug strategies.
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Career opportunities: A curated list of new positions, including a Research Associate, a Senior Research Scientist, and a Post-doctoral Researcher position focused on GPCRs and Mitochondria. Must-read publications: New insights on RGS protein modulation, GRK2-biased β₂AR signaling, and the If you’re not there, you’re missing out on the next wave of allosteric modulators, biased ligands, and Gain a competitive edge by staying on top of the latest breakthroughs in allostery, biased signaling,
- Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
2022 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today reported its half-year and second quarter financial
- 📰 GPCR Weekly News, March 13 to 19, 2023
A Rab10-ACAP1-Arf6 GTPases cascade modulates M4 muscarinic acetylcholine receptor trafficking and signaling Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator. α1-adrenoceptor Endogenous l- to d-amino acid residue isomerization modulates selectivity between distinct neuropeptide (July 2 - 7, 2023). 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Jobs Postdoctoral positions
- 📰 GPCR Weekly News, May 27 to June 2, 2024
, can effectively measure the strength of an allosteric effect as agonist's efficacy Single transmembrane GPCR modulating proteins: neither single nor simple Structural and Molecular Insights into GPCR Function selectivity and antagonism in extracellular GPCR-nanobodies Industry News Structure Therapeutics Reports Positive Medical Affairs Septerna to Participate in the Jefferies Global Healthcare Conference Crinetics Announces Positive Fellow—Pharmacology/Cell Biology/Biochemistry Post Doctoral Fellow Postdoc Position Join Dr.
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Dopamine D2 receptor modulators – transforming treatment for Parkinson’s & schizophrenia. Allosteric modulation for unprecedented precision. Serotonin & dopamine receptor modulation for neuropsychiatric disorders. These sessions bridge structural biology , computational modeling , and clinical translation — with
- How GPCR Collaboration Built an Innovation Engine
But in Melbourne, a quiet experiment challenged that model — and it worked. Funding models rewarded independence, not shared resources. Engineering Collaboration: The Monash Lab Model Traditional academic labs mirror feudal structures. The Monash model flipped that logic: Shared infrastructure, not duplicated equipment Centralized core What Changed After This Data The pooled funding model turned the lab into a magnet: postdocs, visiting
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
peptides designed from the intracellular loops of G protein-coupled receptors (GPCRs) that act in an allosteric manner to modulate the activity of GPCRs.
- G protein-coupled receptors that influence lifespan of human and animal models
analysis of a series of GPCRs whose activity has been shown to affect the lifespan of animal and human models
- Addex Raises $10 Million In Equity Financing
Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it has entered into a definitive
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Signaling Sonja Peter , Brian Bender , Chris De Graaf for their excellent work on Comparative Study of Allosteric infection: IUPHAR Review 41 Structural and Molecular Insights into GPCR Function Comparative Study of Allosteric
- 📰 GPCR Weekly News, June 3 to June 9, 2024
factor-dependent phosphorylation of Gαi shapes canonical signaling by G protein-coupled receptors Kinetic Model epithelial cells GPCR Binders, Drugs, and more Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1 GPCR function in autophagy control: a systematic approach of chemical Treg Depleting anti-CCR8 Antibodies, Including Best-in-class Candidate DT-7012 Crinetics Announces Positive Fellow—Pharmacology/Cell Biology/Biochemistry Post Doctoral Fellow Postdoc Position Join Dr.
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
By modulating receptor expression or sensitivity, we can shift the “lens” through which drug activity Model patient-like pathophysiological states (e.g., reduced receptor expression in heart failure). Adjusting assay sensitivity—whether through expression systems, chemical modulation, or engineered desensitization—provides What emerges is not just more data—it’s the right data, positioned to inform strategic decision-making If you’re still treating orthosteric and allosteric interactions as interchangeable, you’re leaving precision
- Addex raises $4.2 million in equity financing
Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it has entered into a definitive
- 📰 GPCR Weekly News, February 12 to 18, 2024
agonism by Gαi/o-biased stapled peptide agonists of the relaxin-3 receptor GPCR kinases differentially modulate cannabinoid receptor agonists at the cannabinoid CB1 receptor Why classical receptor theory, which ignores allostery , can effectively measure the strength of an allosteric effect as agonist's efficacy GPCR Binders, Drugs Imaging Center Scientific Assistant Postdoctoral Fellowship- Mechanistic Biology Research Scientist Post-Doc position Join Dr.
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
A conserved intracellular allosteric binding site (IABS) has recently been identified at several G protein-coupled showing that our CCR9-PROTAC is able to reduce CCR9 levels, thereby offering an unprecedented approach to modulate
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
disturbances GPCR Binders, Drugs, and more Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptors GPCRs in Neuroscience In-silico predicted mouse melanopsins with Caenorhabditis elegans Calcium-sensing receptor regulates Kv7 channels via Gi/o protein signalling and modulates antigens enable drug discovery and development Mapping GPCR-RAMP complexes with MolBoolean Screening GPR75 Modulators Postdoctoral research position Senior or Lead Researcher Senior Scientist, Cryo-Electron Microscopy
- Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinet
Monitoring intracellular cAMP levels can help identify orthosteric agonists and antagonists, as well as allosteric modulators.
- A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr
We report that arrestin-3 modulates Fgr activity with a hallmark bell-shaped concentration-dependence interaction, we determined the crystal structure of the Fgr SH3 domain at 1.9 Å resolution and developed a model This model suggests that Fgr interacts with arrestin-3 at multiple sites and is consistent with the locations
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
They stall when chemistry, modeling, and pharmacology drift apart. Breakthroughs this week: 12th Adhesion GPCR Workshop (Düsseldorf, Sept 16–18, 2026); Free fatty acid receptor 2 allosterism These sessions span foundational pharmacology, receptor biology, modeling, translational strategy, and partnership connects advanced assay and biology capabilities with the scientists and organizations positioned
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
Breakthroughs this week: C. elegans avoids EGCG via SRXA-7 GPCR; a bidirectional GPCR switch modulates immune signaling; a machine-learning tool predicts GPCR–ligand kinetics; and cryo-EM uncovers a new allosteric We kick off with a question that cuts deep: What if your models could actually predict the future? Jens Carlsson (Uppsala University) joins Yamina to explore how computational modeling is evolving from
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
From restricted tissue diffusion to PK–PD dissociation, Kenakin equips you with the kinetic models and In This Session, You’ll Gain: ✅ Modeling tools to understand how restricted diffusion in tissues like window ✅ Examples of how rebinding in dense receptor environments amplifies target occupancy, even post-clearance PK–PD Dissociation: When Clearance Doesn’t Mean It’s Over The lecture’s standout example: Aplaviroc, an allosteric Kenakin offers not just theory, but tools to model, predict, and validate this behavior early.
- 📰 GPCR Weekly News - January 9 to 15, 2023
Mandibulofacial dysostosis with alopecia results from gain-of-ETAR function via allosteric effects on GPCR Binders, Drugs, and more Modelling altered signalling of G-protein coupled receptors in inflamed GPCR Allostery: a View from Computational Biology.
- 📰 GPCR Weekly News, September 4 to 10, 2023
GPCR Symposium on ''GPCRs as Therapeutic Modalities' Share your project with a 1-minute abstract video involved in the innate immune response of Tribolium castaneum GPCR Activation and Signaling Biased allosteric Discovery On Target September 27 - 28, 2023 | Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric
- 📰 GPCR Weekly News, July 10 to 16, 2023
GPCR Binders, Drugs, and more Allosteric modulator potentiates β2AR agonist-promoted bronchoprotection in asthma models.
- Dr. GPCR University registration is now open! Secure your spot now!
Expression Ligand bias at the muscarinic acetylcholine receptor family: opportunities and challenges Modulating Structural and Molecular Insights into GPCR Function Vibrational Energy Landscapes and Energy Flow in GPCRs Allosterism Industry News Confo Therapeutics Announces EUR 60M Series B Financing to Advance a Pipeline of Novel GPCR-Modulating July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs NEW Postdoctoral Position NEW Postdoctoral research position Senior or Lead Researcher Senior Scientist, Cryo-Electron Microscopy
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Career opportunities: New openings for a postdoctoral research position in GPCR biochemistry and biophysics Avoid missed opportunities: Discover how to identify and target cryptic intracellular allosteric sites GPCR Podcast : The Future of GPCR Drug Discovery with Molecular Modeling The field of GPCR research is Learn how his research aims to develop models that can distinguish between active and inactive ligands
- G protein coupling and activation of the metabotropic GABAB heterodimer
September 2022 "Metabotropic γ-aminobutyric acid receptor (GABABR), a class C G protein-coupled receptor (GPCR) heterodimer, plays a crucial role in the central nervous system. Cryo-electron microscopy studies revealed a drastic conformational change upon activation and a unique G protein (GP) binding mode. However, little is known about the mechanism for GP coupling and activation for class C GPCRs. Here, we use molecular metadynamics computations to predict the mechanism by which the inactive GP induces conformational changes in the GABABR transmembrane domain (TMD) to form an intermediate pre-activated state. We find that the inactive GP first interacts with TM3, which further leads to the TMD rearrangement and deeper insertion of the α5 helix that causes the Gα subunit to open, releasing GDP, and forming the experimentally observed activated structure. This mechanism provides fresh insights into the mechanistic details of class C GPCRs activation expected to be useful for designing selective agonists and antagonists." Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, February 5 to 11, 2024
5th to 11th, 2024 GPCR Activation and Signaling Constitutive activation mechanism of a class C GPCR Allosteric modulation and G-protein selectivity of the Ca2+-sensing receptor GPCRs in Cardiology, Endocrinology Research GPCR-BERT: Interpreting Sequential Design of G Protein-Coupled Receptors Using Protein Language Models Imaging Center NEW Scientific Assistant Postdoctoral Fellowship- Mechanistic Biology Research Scientist Post-Doc position Lead Researcher Join Dr.
- 📰 GPCR Weekly News, June 5 to 11, 2023
Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization. The G protein-coupled receptor neuropeptide receptor-15 modulates larval development via the transforming Stabilization of pre-existing neurotensin receptor conformational states by β-arrestin-1 and the biased allosteric modulator ML314. Scientist II DOE (Native Mass Spectrometry) Senior Vice President of Global Medical Affairs Postdoctoral Position












